These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 36210729)
1. Inhibition of autophagy impairs free fatty acid-induced excessive lipid accumulation in hepatocellular carcinoma and hepatic cells. Chen X; Liu H; Chen K; Guo Y; Mo T; Gao T J Biosci; 2022; 47():. PubMed ID: 36210729 [TBL] [Abstract][Full Text] [Related]
2. [Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy]. Shi YM; Fu ZH; Zhu CS; Li XP Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1770-1778. PubMed ID: 37282951 [TBL] [Abstract][Full Text] [Related]
3. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. Chavez-Tapia NC; Rosso N; Tiribelli C BMC Gastroenterol; 2012 Mar; 12():20. PubMed ID: 22380754 [TBL] [Abstract][Full Text] [Related]
4. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway. Yan LS; Zhang SF; Luo G; Cheng BC; Zhang C; Wang YW; Qiu XY; Zhou XH; Wang QG; Song XL; Pan SY; Zhang Y Metabolism; 2022 Jun; 131():155200. PubMed ID: 35405150 [TBL] [Abstract][Full Text] [Related]
5. Liraglutide reduces lipid accumulation in steatotic L‑02 cells by enhancing autophagy. Zhou SW; Zhang M; Zhu M Mol Med Rep; 2014 Nov; 10(5):2351-7. PubMed ID: 25230688 [TBL] [Abstract][Full Text] [Related]
6. The ménage à trois of autophagy, lipid droplets and liver disease. Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741 [TBL] [Abstract][Full Text] [Related]
7. ω-3 Fatty acids reverse lipotoxity through induction of autophagy in nonalcoholic fatty liver disease. Chen Y; Xu C; Yan T; Yu C; Li Y Nutrition; 2015; 31(11-12):1423-1429.e2. PubMed ID: 26429665 [TBL] [Abstract][Full Text] [Related]
9. Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model. Im AR; Kim YH; Lee HW; Song KH J Med Food; 2016 May; 19(5):495-503. PubMed ID: 27152979 [TBL] [Abstract][Full Text] [Related]
10. Magnesium Supplementation Stimulates Autophagy to Reduce Lipid Accumulation in Hepatocytes via the AMPK/mTOR Pathway. Chen S; Luo S; Zou B; Xie J; Li J; Zeng Y Biol Trace Elem Res; 2023 Jul; 201(7):3311-3322. PubMed ID: 36224316 [TBL] [Abstract][Full Text] [Related]
11. Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line. Zhou D; Li BH; Wang J; Ding YN; Dong Y; Chen YW; Fan JG PLoS One; 2016; 11(10):e0165224. PubMed ID: 27760195 [TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway. Xue W; Wang J; Jiang W; Shi C; Wang X; Huang Y; Hu C Eur J Pharmacol; 2020 Mar; 871():172910. PubMed ID: 31926991 [TBL] [Abstract][Full Text] [Related]
13. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Long JK; Dai W; Zheng YW; Zhao SP Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981 [TBL] [Abstract][Full Text] [Related]
14. Blueberry polyphenols play a preventive effect on alcoholic fatty liver disease C57BL/6 J mice by promoting autophagy to accelerate lipolysis to eliminate excessive TG accumulation in hepatocytes. Zhuge Q; Zhang Y; Liu B; Wu M Ann Palliat Med; 2020 May; 9(3):1045-1054. PubMed ID: 32389004 [TBL] [Abstract][Full Text] [Related]
15. Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models. Yan R; Niu CY; Tian Y Arch Med Res; 2018 Aug; 49(6):381-390. PubMed ID: 30573200 [TBL] [Abstract][Full Text] [Related]
16. FMO1 Promotes Nonalcoholic Fatty Liver Disease Progression by Regulating PPARα Activation and Inducing Ferroptosis. Zou L; Shi Q; Li Y; Yuan Z; Peng L; Lu J; Zhu H; Ma J Discov Med; 2023 Aug; 35(177):612-622. PubMed ID: 37553313 [TBL] [Abstract][Full Text] [Related]
17. Cellular and molecular alterations in a human hepatocellular in vitro model of nonalcoholic fatty liver disease development and stratification. Willett RA; Tryndyak VP; Beland FA; Pogribny IP J Environ Sci Health C Toxicol Carcinog; 2024; 42(1):74-92. PubMed ID: 38105681 [TBL] [Abstract][Full Text] [Related]
19. [Urolithin A inhibits inflammation and oxidative stress induced by high lipid in hepatocytes via activating Nrf2 pathway and autophagy]. Yin C; Wang Y; Peng Y; Zhang R; Sun N; Shi C; Liu Q Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Nov; 37(11):973-980. PubMed ID: 34809736 [TBL] [Abstract][Full Text] [Related]